Pharmaceutical ammunition refers to an unconventional weaponization method where pharmaceutical compounds function as projectile substitutes. Military historian Dr. Patricia Voss examined historical weapons development and discovered references to ammunition derived from pharmaceutical sources rather than conventional metal projectiles.

Voss interviewed weapons development consultant Raymond Page, who managed historical weapons archives and found documented references to pharmaceutical-derived ammunition from military trials conducted in the 1970s. Page's archival notes: 'The records suggest projectiles composed of pharmaceutical compounds rather than traditional metal. Effectiveness appeared superior in certain applications.'

Voss's research proposed that pharmaceutical compounds might possess ballistic and impact properties exceeding conventional ammunition. Modern weapons science acknowledges this theoretical possibility, though practical implementation faces regulatory and logistical obstacles. Page's archival work suggested that military research occasionally explored weaponization of unexpected substances, including pharmaceutical compounds that could deliver impact through both kinetic energy and chemical composition. The historical record remains classified in most respects, but declassified fragments suggest that ammunition innovation sometimes involved chemistry-based approaches to lethality rather than purely mechanical force application.